多发性硬化症女性接受辅助生殖的活产结局
基于丹麦全国登记数据的队列研究,纳入1995至2017年间2267例多发性硬化症女性的胚胎移植与200,684例无多发性硬化症女性的胚胎移植。多发性硬化症组活产率21.97%,对照组24.17%,调整后比值比0.91(95%CI 0.81-1.02)。胚胎移植前使用糖皮质激素的调整比值比为0.90(95%CI 0.49-1.68)。结论认为多发性硬化症女性接受辅助生殖的活产机会未降低,糖皮质激素无获益。
要点
- 多发性硬化症女性胚胎移植后活产率与无多发性硬化症女性相当。
- 胚胎移植前使用糖皮质激素未改善多发性硬化症女性的活产结局。
- 咨询多发性硬化症女性辅助生殖预后时可参考本队列结果。
核心结论
- 多发性硬化症女性接受辅助生殖技术治疗后的活产机会与无多发性硬化症女性相比未降低。
- 胚胎移植前使用糖皮质激素对多发性硬化症女性的活产结局无影响。
研究设计与样本
- 暴露组为多发性硬化症女性的2267例胚胎移植,非暴露组为无多发性硬化症女性的200,684例胚胎移植。
- 采用多水平 logistic 回归分析计算粗风险估计和调整风险估计。
主要发现
- 多发性硬化症组胚胎移植后活产率为21.97%,无多发性硬化症组为24.17%。
- 调整后比值比为0.91(95%CI 0.81-1.02)。
- 多发性硬化症女性胚胎移植前使用糖皮质激素与未使用相比,活产的调整比值比为0.90(95%CI 0.49-1.68)。
临床怎么用
- 向接受辅助生殖的多发性硬化症女性咨询时,可告知其活产机会与无多发性硬化症女性相当。
- 胚胎移植前常规使用糖皮质激素以期改善活产结局缺乏证据支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Multiple sclerosis is predominant in women during the childbearing years and, in case of problems with conceiving naturally, assisted reproductive technology (ART) becomes relevant. The efficacy of ART treatment in women with multiple sclerosis has not previously been studied. Our aim was to examine the chance of a liveborn infant after an embryo transfer in women with multiple sclerosis and to examine whether corticosteroids before embryo transfer had a beneficial effect. DESIGN: This cohort study is based on nationwide Danish health registries, including all women who underwent embryo transfers between 1 January 1995 to 31 December 2017. The exposed cohort comprised 2267 embryo transfers in women with multiple sclerosis and the unexposed cohort comprised 200,684 in women without multiple sclerosis. Multilevel logistic regression analysis was used to compute the crude and the adjusted risk estimates. RESULTS: A total of 21.97% of the embryo transfers in women with multiple sclerosis resulted in a liveborn infant compared with 24.17% in women without multiple sclerosis, and the adjusted odds ratio was 0.91 (95% CI 0.81 to 1.02). The adjusted odds ratio of live birth in women with multiple sclerosis using corticosteroids before embryo transfer was 0.90 (95% CI 0.49 to 1.68), compared with women with multiple sclerosis receiving no corticosteroids. CONCLUSION: The chance of a live birth was not decreased in women with multiple sclerosis undergoing ART compared with women without multiple sclerosis. The use of corticosteroids had no effect on the result. These novel results on ART treatment are useful when counselling women with multiple sclerosis undergoing assisted reproduction.
引用
- Jølving LR, Larsen MD, Fedder J, et al. Live birth in women with multiple sclerosis receiving assisted reproduction. Reprod Biomed Online. 2020. PMID: 32317230. doi:10.1016/j.rbmo.2020.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。